Impact of Grip Strength in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib

被引：31

作者：

Endo, Kei ^{[1
]}

Kuroda, Hidekatsu ^{[1
]}

Kanazawa, Jo ^{[1
]}

Sato, Takuro ^{[1
]}

Fujiwara, Yudai ^{[1
]}

Abe, Tamami ^{[1
]}

Sato, Hiroki ^{[1
]}

Kooka, Youhei ^{[1
]}

Oikawa, Takayoshi ^{[1
]}

Sawara, Kei ^{[1
]}

Takikawa, Yasuhiro ^{[1
]}

机构：

[1] Iwate Med Univ, Div Hepatol, Dept Internal Med, Sch Med, Morioka, Iwate 0283695, Japan

来源：

CANCERS | 2020年 / 12卷 / 08期

关键词：

sarcopenia; grip strength; skeletal muscle index; hepatocellular carcinoma; lenvatinib; modified albumin-bilirubin grade; MUSCLE MASS; SARCOPENIA; SORAFENIB; MORTALITY;

D O I：

10.3390/cancers12082146

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Although sarcopenia is characterized by a loss of muscle strength and skeletal muscle mass, few studies have evaluated the effect of muscle strength on hepatocellular carcinoma (HCC) patients. We evaluated the impact of sarcopenia-related factors (grip strength (GS) and the skeletal muscle index (SMI)) on the survival among lenvatinib-treated unresectable HCC (u-HCC) patients. This single-center cohort study was conducted at a university hospital. The study population included 63 lenvatinib-treated u-HCC patients managed between April 2018 and April 2020. A decreased GS and decreased SMI were found in 21 (33.3%) and 22 (34.9%) patients, respectively. The overall survival (OS) of the normal GS group was significantly higher than that of the decreased GS group, while that of the normal and decreased SMI groups did not differ markedly. There were no significant differences in the progression-free survival between the normal GS and decreased GS groups or the normal SMI and decreased SMI groups. A multivariate Cox proportional hazards model showed that modified albumin-bilirubin-grade (mALBI) 2b (hazard ratio (HR) 4.39) and a decreased GS (HR 3.55) were independently associated with an increased risk of poor prognosis. In addition to the hepatic functional reserve, a decreased GS was a poor prognostic factor in lenvatinib-treated u-HCC patients.

引用

页码：1 / 15

页数：15

共 36 条

[1]

[Anonymous], 2019, CANCERS

[2] Sarcopenia is associated with reduced survival in patients with advanced hepatocellular carcinoma undergoing sorafenib treatment [J].

Antonelli, Giulio ;

Gigante, Elia ;

Iavarone, Massimo ;

Begini, Paola ;

Sangiovanni, Angelo ;

Iannicelli, Elsa ;

Biondetti, Piero ;

Pellicelli, Adriano M. ;

Miglioresi, Lucia ;

Marchetti, Paolo ;

Lampertico, Pietro ;

Marignani, Massimo .

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2018, 6 (07) :1039-1048

[3] Sarcopenia and the cardiometabolic syndrome: A narrative review [J].

Bahat, G. ;

Ilhan, B. .

EUROPEAN GERIATRIC MEDICINE, 2016, 7 (03) :220-223

[4] Sarcopenia and frailty in chronic respiratory disease: Lessons from gerontology [J].

Bone, Anna E. ;

Hepgul, Nilay ;

Kon, Samantha ;

Maddocks, Matthew .

CHRONIC RESPIRATORY DISEASE, 2017, 14 (01) :85-99

[5] ESPEN guidelines on definitions and terminology of clinical nutrition [J].

Cederholm, T. ;

Barazzoni, R. ;

Austin, P. ;

Ballmer, P. ;

Biolo, G. ;

Bischoff, S. C. ;

Compher, C. ;

Correia, I. ;

Higashiguchi, T. ;

Hoist, M. ;

Jensen, G. L. ;

Malone, A. ;

Muscaritoli, M. ;

Nyulasi, I. ;

Pirlich, M. ;

Rothenberg, E. ;

Schindler, K. ;

Schneider, S. M. ;

de van der Schueren, M. A. E. ;

Sieber, C. ;

Valentini, L. i ;

Yu, J. C. ;

Van Gossum, A. ;

Singer, P. .

CLINICAL NUTRITION, 2017, 36 (01) :49-64

[6] GLIM Criteria Using Hand Grip Strength Adequately Predict Six-Month Mortality in Cancer Inpatients [J].

Contreras-Bolivar, Victoria ;

Jose Sanchez-Torralvo, Francisco ;

Ruiz-Vico, Maria ;

Gonzalez-Almendros, Inmaculada ;

Barrios, Manuel ;

Padin, Susana ;

Alba, Emilio ;

Olveira, Gabriel .

NUTRIENTS, 2019, 11 (09)

[7] Sarcopenia: revised European consensus on definition and diagnosis [J].

Cruz-Jentoft, Alfonso J. ;

Bahat, Gulistan ;

Bauer, Juergen ;

Boirie, Yves ;

Bruyere, Olivier ;

Cederholm, Tommy ;

Cooper, Cyrus ;

Landi, Francesco ;

Rolland, Yves ;

Sayer, Avan Aihie ;

Schneider, Stephane M. ;

Sieber, Cornel C. ;

Topinkova, Eva ;

Vandewoude, Maurits ;

Visser, Marjolein ;

Zamboni, Mauro .

AGE AND AGEING, 2019, 48 (01) :16-31

[8] Sustained virologic response by direct-acting antivirals suppresses skeletal muscle loss in hepatitis C virus infection [J].

Endo, Kei ;

Sato, Takuro ;

Suzuki, Akiko ;

Yoshida, Yuichi ;

Kakisaka, Keisuke ;

Miyasaka, Akio ;

Takikawa, Yasuhiro .

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 (09) :1602-1609

[9]

European Assoc Study Liver, 2018, J HEPATOL, V69, P182, DOI 10.1016/j.jhep.2018.03.019

[10] Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma [J].

Fujiwara, Naoto ;

Nakagawa, Hayato ;

Kudo, Yotaro ;

Tateishi, Ryosuke ;

Taguri, Masataka ;

Watadani, Takeyuki ;

Nakagomi, Ryo ;

Kondo, Mayuko ;

Nakatsuka, Takuma ;

Minami, Tatsuya ;

Sato, Masaya ;

Uchino, Koji ;

Enooku, Kenichiro ;

Kondo, Yuji ;

Asaoka, Yoshinari ;

Tanaka, Yasuo ;

Ohtomo, Kuni ;

Shiina, Shuichiro ;

Koike, Kazuhiko .

JOURNAL OF HEPATOLOGY, 2015, 63 (01) :131-140

← 1 2 3 4 →